Cleveland Clinic Nephrology Update 2025

Description

Include: 12 videos + 34 pdfs, size: 8 GB

Target Audience: nephrologists, rheumatologists, internists, maternal fetal medicine providers

Information:

Cleveland Clinic Nephrology Update 2025. This year’s update will provide a review of the most up-to-date data and analyze it for implications in clinical practice, as well as focus on the most recent current topics that impact your practice. Cleveland Clinic Nephrology Update 2025 features experts that will address diagnosis and management strategies for patients with kidney disease.

By Attending, You Will Be Able To:

• Describe and critically appraise recent advancements in chronic kidney disease management, including the integration of novel pharmacotherapies such as SGLT2 inhibitors, GLP-receptor agonists, and non-steroidal MRAs into treatment plans.
• Discuss the management of various complications in CKD and ESKD.
• Discuss obesity in CKD and the role of nephrology providers.
• Evaluate the latest evidence-based treatment strategies for IgA nephropathy and lupus nephritis, with a focus on novel therapies.
• Analyze the role of complement activation in various kidney diseases and explore the role of novel therapeutic interventions targeting the complement system.
• Highlight updated approaches to managing kidney-related complications in cancer patients, including the nephrotoxic effects of immune checkpoint inhibitors and targeted cancer therapeutics.
• Review the basics of dialysis vascular access and critically appraise recent advances in the field.
• Assess the unique challenges of managing kidney disease in pregnant patients, including hypertension, preeclampsia, and acute kidney injury, with a focus on balancing maternal and fetal health.

Who Should Attend?

This activity is designed for nephrologists, rheumatologists, internists, maternal fetal medicine providers, nurses, nurse practitioners, physician assistants, and other practicing health care professionals who desire an update on recent advancements in chronic kidney disease management, treatment strategies for IgA nephropathy and lupus nephritis, managing kidney-related complications in cancer patients, and the unique challenges of managing kidney disease in pregnant patients.

+ Topics:

Agenda.pdf
Session I Updates and Challenges in CKD Care (Part 1) Anticoagulation in CKD and ESKD.pdf
Session I Updates and Challenges in CKD Care (Part 1) Calciphylaxis and Skin Issues in CKD.pdf
Session I Updates and Challenges in CKD Care (Part 1) CKD KDIGO Guidelines Update.pdf
Session I Updates and Challenges in CKD Care (Part 1).mp4
Session II Updates and Challenges in CKD Care (Part 2) Hypertension Management in CKD.pdf
Session II Updates and Challenges in CKD Care (Part 2) Nutrition and CKD.pdf
Session II Updates and Challenges in CKD Care (Part 2) Obesity and CKD.pdf
Session II Updates and Challenges in CKD Care (Part 2).mp4
Session III Vascular Access Symposium- An Update for the Nephrologist 1.pdf
Session III Vascular Access Symposium- An Update for the Nephrologist 2.pdf
Session III Vascular Access Symposium- An Update for the Nephrologist 3.pdf
Session III Vascular Access Symposium.mp4
Session IV Journal Club 1.pdf
Session IV Journal Club 2.pdf
Session IV Journal Club.mp4
Session V Updates in Glomerular Diseases (Part 1) Genetics in Primary Nephrotic Syndrome.pdf
Session V Updates in Glomerular Diseases (Part 1) Kidney Success- Clinical Trials in Nephrology.pdf
Session V Updates in Glomerular Diseases (Part 1) Update in Primary Nephrotic Syndrome.pdf
Session V Updates in Glomerular Diseases (Part 1).mp4
Session VI Updates in Glomerular Diseases (Part 2) CAR-T for Autoimmune diseases.pdf
Session VI Updates in Glomerular Diseases (Part 2) IgA Nephropathy Update.pdf
Session VI Updates in Glomerular Diseases (Part 2) Lupus Nephritis Update.pdf
Session VI Updates in Glomerular Diseases (Part 2).mp4
Session VII Kasperzak Lecture and Case Discussions Clinicopathologic Case Discussions.pdf
Session VII Kasperzak Lecture and Case Discussions Kasperzak Lecture- Complement in Kidney Diseases 1.pdf
Session VII Kasperzak Lecture and Case Discussions Kasperzak Lecture- Complement in Kidney Diseases 2.pdf
Session VII Kasperzak Lecture and Case Discussions.mp4
Session VIII Vasculitis Update and Case Discussions Clinicopathologic Case Discussions.pdf
Session VIII Vasculitis Update and Case Discussions Vasculitis Mimics.pdf
Session VIII Vasculitis Update and Case Discussions What’s New in Vasculitis.pdf
Session VIII Vasculitis Update and Case Discussions.mp4
Session IX Update in Onco-nephrology Case Discussions in Onconephrology.pdf
Session IX Update in Onco-nephrology Immunotherapy and the Kidneys.pdf
Session IX Update in Onco-nephrology TKI and VEGF Inhibitors.pdf
Session IX Update in Onco-nephrology.mp4
Session X Monoclonal Gammopathy of Renal Significance (MGRS) A Primer into MGRS- What a Nephrologist Should Know.pdf
Session X Monoclonal Gammopathy of Renal Significance (MGRS) Case Discussions in MGRS.pdf
Session X Monoclonal Gammopathy of Renal Significance (MGRS).mp4
Session XI Obstetric Nephrology AKI in Pregnancy.pdf
Session XI Obstetric Nephrology Case Discussions in Obstetric Nephrology.pdf
Session XI Obstetric Nephrology GN in Pregnancy CKD Pregnancy Counseling.pdf
Session XI Obstetric Nephrology.mp4
Session XII Updates in the World of Kidney Transplantation Medical Updates in Kidney Transplant.pdf
Session XII Updates in the World of Kidney Transplantation Surgical Updates in Kidney Transplant.pdf
Session XII Updates in the World of Kidney Transplantation.mp4